Phage Biobank: Present Challenges and Future Perspectives.

Last updated on 3-1-2022 by Pieter-Jan Ceyssens

Peer reviewed scientific article




After a century of use in human infection, the preparation and administration of therapeutic bacteriophages (phages) still relies on ad hoc partnerships of researchers, biotech companies, clinicians and regulators. There is a clear need to improve the reproducibility, safety and speed of the provision of suitable phages. Here we discuss the specific characteristics and challenges of a sustainable phage biobank and, as we build a national consortium aimed at delivering phage therapeutics, suggest a roadmap toward national biobanking and phage therapy initiatives using the Australian context …

QR code

QR code for this page URL